The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest cell and gene therapy market share.

The global cell and gene therapy market is expected to grow from $8.57 billion in 2022 to $10.95 billion in 2023 at a compound annual growth rate (CAGR) of 27.8%. The cell and gene therapy market is expected to grow from $26.21 billion in 2027 at a CAGR of 24.4%.

Major Driver In The Cell And Gene Therapy Market ­– Increase In Production Capacity
In April 2020, Merck, for example, invested $109 million in viral vector and gene therapy manufacturing. Furthermore, CGT is present in 12% of industrial clinical pipeline medicines and at least 16% of preclinical pipeline products. Consistent investment and consolidation in CGT production capacity increased production capacity and contributed to market growth.

View More On The Cell And Gene Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Key Cell And Gene Therapy Market Segments
1) By Product: Cell Therapy, Gene Therapy
2) By Application: Oncology, Dermatology, Musculoskeletal, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Recent Cell And Gene Therapy Market Trend – Adopting Chimeric Antigen Receptor T-Cell Therapy
T-cell therapy is a cell and gene therapy combination in which T cells are harvested from the patient’s blood and genetically manipulated to create modified receptors on their surface known as chimeric antigen receptors (CARs). These modified T cells, which contain particular structures (receptors), are then reinfused into the patient. The changed T cell receptors then aid in targeting the surface antigen of the cancer cell, resulting in the death of tumour cells in patients. The US-FDA approved and plans to introduce Bristol-Myers Squibb’s two CAR-T cell treatments for lymphoma and multiple myeloma in 2020. Tisagenlecleucel for the treatment of B-cell precursor acute lymphoblastic leukaemia (ALL) in children and Axicabtageneciloleucel for the treatment of adult patients with relapsed or refractory large B-cell lymphoma are now FDA-approved CAR-T cell therapy therapies.

Cell And Gene Therapy Market Prominent Players
Major players in the cell and gene therapy market are Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, and Fibrocell Science.

Request A Sample Of The Global Cell And Gene Therapy Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

The Cell And Gene Therapy Global Market Report 2023  provides a comprehensive overview on the cell and gene therapy market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the cell and gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Gene therapy entails the delivery of genetic material, often in the form of a carrier or vector, and the incorporation of the gene into the appropriate bodily cells. Cell treatment entails introducing cells with the right function into the patient. Some treatments combine cell therapy and gene therapy.

View More Related Reports –
Cell Therapy Global Market Report 2023
Cellular Immunotherapy Global Market Report 2023
Cell Based Assays Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model